Sagot Y - Search Results

1

Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy.

Cox AA, Sagot Y, Hedou G, Grek C, Wilkes T, Vinik AI, Ghatnekar G. Cox AA, et al. Among authors: sagot y. Front Endocrinol (Lausanne). 2017 May 2;8:89. doi: 10.3389/fendo.2017.00089. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28512447 Free PMC article. Review.

2

Interleukin-6 potentiates endurance training adaptation and improves functional capacity in old mice.

Leuchtmann AB, Furrer R, Steurer SA, Schneider-Heieck K, Karrer-Cardel B, Sagot Y, Handschin C. Leuchtmann AB, et al. Among authors: sagot y. J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):1164-1176. doi: 10.1002/jcsm.12949. Epub 2022 Feb 22. J Cachexia Sarcopenia Muscle. 2022. PMID: 35191221 Free PMC article.

3

Regulation of LRRK2 expression points to a functional role in human monocyte maturation.

Thévenet J, Pescini Gobert R, Hooft van Huijsduijnen R, Wiessner C, Sagot YJ. Thévenet J, et al. Among authors: sagot yj. PLoS One. 2011;6(6):e21519. doi: 10.1371/journal.pone.0021519. Epub 2011 Jun 27. PLoS One. 2011. PMID: 21738687 Free PMC article.

4

Chemical inducers and transcriptional markers of oligodendrocyte differentiation.

Joubert L, Foucault I, Sagot Y, Bernasconi L, Duval F, Alliod C, Frossard MJ, Pescini Gobert R, Curchod ML, Salvat C, Nichols A, Pouly S, Rommel C, Roach A, Hooft van Huijsduijnen R. Joubert L, et al. Among authors: sagot y. J Neurosci Res. 2010 Sep;88(12):2546-57. doi: 10.1002/jnr.22434. J Neurosci Res. 2010. PMID: 20544820

5

Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies.

Dati G, Quattrini A, Bernasconi L, Malaguti MC, Antonsson B, Nicoletti F, Alliod C, Di Marco R, Sagot Y, Vitte PA, Hiver A, Greco B, Roach A, Zaratin PF. Dati G, et al. Among authors: sagot y. J Neuroimmunol. 2007 Oct;190(1-2):8-17. doi: 10.1016/j.jneuroim.2007.07.014. Epub 2007 Aug 21. J Neuroimmunol. 2007. PMID: 17714795

6

IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS.

Heckmann A, Waltzinger C, Jolicoeur P, Dreano M, Kosco-Vilbois MH, Sagot Y. Heckmann A, et al. Among authors: sagot y. Am J Pathol. 2004 Apr;164(4):1253-62. doi: 10.1016/S0002-9440(10)63213-0. Am J Pathol. 2004. PMID: 15039214 Free PMC article.

7

Phosphatidylinositol 3-kinase activity in murine motoneuron disease: the progressive motor neuropathy mouse.

Wagey R, Lurot S, Perrelet D, Pelech SL, Sagot Y, Krieger C. Wagey R, et al. Among authors: sagot y. Neuroscience. 2001;103(1):257-66. doi: 10.1016/s0306-4522(00)00551-0. Neuroscience. 2001. PMID: 11311806

8

An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease.

Sagot Y, Toni N, Perrelet D, Lurot S, King B, Rixner H, Mattenberger L, Waldmeier PC, Kato AC. Sagot Y, et al. Br J Pharmacol. 2000 Oct;131(4):721-8. doi: 10.1038/sj.bjp.0703633. Br J Pharmacol. 2000. PMID: 11030721 Free PMC article.

9

IAP family proteins delay motoneuron cell death in vivo.

Perrelet D, Ferri A, MacKenzie AE, Smith GM, Korneluk RG, Liston P, Sagot Y, Terrado J, Monnier D, Kato AC. Perrelet D, et al. Among authors: sagot y. Eur J Neurosci. 2000 Jun;12(6):2059-67. doi: 10.1046/j.1460-9568.2000.00098.x. Eur J Neurosci. 2000. PMID: 10886345

10

NGF-induced motoneuron cell death depends on the genetic background and motoneuron sub-type.

Terrado J, Monnier D, Perrelet D, Sagot Y, Mattenberger L, King B, Kato AC. Terrado J, et al. Among authors: sagot y. Neuroreport. 2000 May 15;11(7):1473-7. Neuroreport. 2000. PMID: 10841360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters